<!DOCTYPE html>
<html lang="en" dir="ltr" class="client-nojs">
<head>
<meta charset="UTF-8" />
<title>Carnitine palmitoyltransferase II deficiency - Wikipedia, the free encyclopedia</title>
<meta name="generator" content="MediaWiki 1.26wmf13" />
<link rel="alternate" href="android-app://org.wikipedia/http/en.m.wikipedia.org/wiki/Carnitine_palmitoyltransferase_II_deficiency" />
<link rel="alternate" type="application/x-wiki" title="Edit this page" href="/w/index.php?title=Carnitine_palmitoyltransferase_II_deficiency&amp;action=edit" />
<link rel="edit" title="Edit this page" href="/w/index.php?title=Carnitine_palmitoyltransferase_II_deficiency&amp;action=edit" />
<link rel="apple-touch-icon" href="/static/apple-touch/wikipedia.png" />
<link rel="shortcut icon" href="/static/favicon/wikipedia.ico" />
<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (en)" />
<link rel="EditURI" type="application/rsd+xml" href="//en.wikipedia.org/w/api.php?action=rsd" />
<link rel="alternate" hreflang="x-default" href="/wiki/Carnitine_palmitoyltransferase_II_deficiency" />
<link rel="copyright" href="//creativecommons.org/licenses/by-sa/3.0/" />
<link rel="alternate" type="application/atom+xml" title="Wikipedia Atom feed" href="/w/index.php?title=Special:RecentChanges&amp;feed=atom" />
<link rel="canonical" href="https://en.wikipedia.org/wiki/Carnitine_palmitoyltransferase_II_deficiency" />
<link rel="stylesheet" href="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=ext.uls.nojs%7Cext.visualEditor.viewPageTarget.noscript%7Cext.wikihiero%7Cmediawiki.legacy.commonPrint%2Cshared%7Cmediawiki.sectionAnchor%7Cmediawiki.skinning.interface%7Cmediawiki.ui.button%7Cskins.vector.styles%7Cwikibase.client.init&amp;only=styles&amp;skin=vector&amp;*" />
<meta name="ResourceLoaderDynamicStyles" content="" />
<link rel="stylesheet" href="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=site&amp;only=styles&amp;skin=vector&amp;*" />
<style>a:lang(ar),a:lang(kk-arab),a:lang(mzn),a:lang(ps),a:lang(ur){text-decoration:none}
/* cache key: global:resourceloader:filter:minify-css:7:de1ab5287c9076b96eedd3f97a84a7b6 */</style>
<script src="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=startup&amp;only=scripts&amp;skin=vector&amp;*"></script>
<script>if(window.mw){
mw.config.set({"wgCanonicalNamespace":"","wgCanonicalSpecialPageName":false,"wgNamespaceNumber":0,"wgPageName":"Carnitine_palmitoyltransferase_II_deficiency","wgTitle":"Carnitine palmitoyltransferase II deficiency","wgCurRevisionId":659864798,"wgRevisionId":659864798,"wgArticleId":2525632,"wgIsArticle":true,"wgIsRedirect":false,"wgAction":"view","wgUserName":null,"wgUserGroups":["*"],"wgCategories":["Articles with contributors link","Articles that use a Medicine navs subtemplate","Autosomal recessive disorders","Hepatology","Fatty-acid metabolism disorders"],"wgBreakFrames":false,"wgPageContentLanguage":"en","wgPageContentModel":"wikitext","wgSeparatorTransformTable":["",""],"wgDigitTransformTable":["",""],"wgDefaultDateFormat":"dmy","wgMonthNames":["","January","February","March","April","May","June","July","August","September","October","November","December"],"wgMonthNamesShort":["","Jan","Feb","Mar","Apr","May","Jun","Jul","Aug","Sep","Oct","Nov","Dec"],"wgRelevantPageName":"Carnitine_palmitoyltransferase_II_deficiency","wgRelevantArticleId":2525632,"wgIsProbablyEditable":true,"wgRestrictionEdit":[],"wgRestrictionMove":[],"wgRedirectedFrom":"Hereditary_carnitine_deficiency_myopathy","wgMediaViewerOnClick":true,"wgMediaViewerEnabledByDefault":true,"wikilove-recipient":"","wikilove-anon":0,"wgPoweredByHHVM":true,"wgWikiEditorEnabledModules":{"toolbar":true,"dialogs":true,"hidesig":true,"preview":false,"publish":false},"wgBetaFeaturesFeatures":[],"wgVisualEditor":{"pageLanguageCode":"en","pageLanguageDir":"ltr","usePageImages":true,"usePageDescriptions":true},"wgGatherShouldShowTutorial":true,"wgGatherPageImageThumbnail":"//upload.wikimedia.org/wikipedia/commons/thumb/3/3e/Autorecessive.svg/85px-Autorecessive.svg.png","wgULSAcceptLanguageList":[],"wgULSCurrentAutonym":"English","wgFlaggedRevsParams":{"tags":{"status":{"levels":1,"quality":2,"pristine":3}}},"wgStableRevisionId":null,"wgCategoryTreePageCategoryOptions":"{\"mode\":0,\"hideprefix\":20,\"showcount\":true,\"namespaces\":false}","wgNoticeProject":"wikipedia","wgInternalRedirectTargetUrl":"/wiki/Carnitine_palmitoyltransferase_II_deficiency","wgWikibaseItemId":"Q2033861"});
}</script><script>if(window.mw){
mw.loader.implement("user.options",function($,jQuery){mw.user.options.set({"variant":"en"});});
/* cache key: global:resourceloader:filter:minify-js:7:b2706269305541eba923c165462b22c4 */
}</script>
<script>if(window.mw){
mw.loader.implement("user.tokens",function($,jQuery){mw.user.tokens.set({"editToken":"+\\","patrolToken":"+\\","watchToken":"+\\"});});
}</script>
<script>if(window.mw){
mw.loader.load(["mediawiki.action.view.redirect","mediawiki.page.startup","mediawiki.legacy.wikibits","mediawiki.legacy.ajax","ext.centralauth.centralautologin","mmv.head","ext.imageMetrics.head","ext.visualEditor.viewPageTarget.init","ext.uls.init","ext.uls.interface","ext.centralNotice.bannerController","skins.vector.js"]);
}</script>
<link rel="dns-prefetch" href="//meta.wikimedia.org" />
<!--[if lt IE 7]><style type="text/css">body{behavior:url("/w/static/1.26wmf13/skins/Vector/csshover.min.htc")}</style><![endif]-->
</head>
<body class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Carnitine_palmitoyltransferase_II_deficiency skin-vector action-view">
		<div id="mw-page-base" class="noprint"></div>
		<div id="mw-head-base" class="noprint"></div>
		<div id="content" class="mw-body" role="main">
			<a id="top"></a>

							<div id="siteNotice"><!-- CentralNotice --></div>
						<div class="mw-indicators">
</div>
			<h1 id="firstHeading" class="firstHeading" lang="en">Carnitine palmitoyltransferase II deficiency</h1>
									<div id="bodyContent" class="mw-body-content">
									<div id="siteSub">From Wikipedia, the free encyclopedia</div>
								<div id="contentSub"><span class="mw-redirectedfrom">  (Redirected from <a href="/w/index.php?title=Hereditary_carnitine_deficiency_myopathy&amp;redirect=no" title="Hereditary carnitine deficiency myopathy">Hereditary carnitine deficiency myopathy</a>)</span></div>
												<div id="jump-to-nav" class="mw-jump">
					Jump to:					<a href="#mw-head">navigation</a>, 					<a href="#p-search">search</a>
				</div>
				<div id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><table class="infobox" style="width:22em">
<tr>
<th colspan="2" style="text-align:center;font-size:125%;font-weight:bold;background-color: lightgrey">Carnitine palmitoyltransferase II deficiency</th>
</tr>
<tr>
<td colspan="2" style="text-align:center"><a href="/wiki/File:Carnitine_structure.png" class="image"><img alt="Carnitine structure.png" src="//upload.wikimedia.org/wikipedia/commons/thumb/8/8d/Carnitine_structure.png/230px-Carnitine_structure.png" width="230" height="79" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/8/8d/Carnitine_structure.png/345px-Carnitine_structure.png 1.5x, //upload.wikimedia.org/wikipedia/commons/8/8d/Carnitine_structure.png 2x" data-file-width="436" data-file-height="150" /></a>
<div><a href="/wiki/Carnitine" title="Carnitine">Carnitine</a></div>
</td>
</tr>
<tr>
<th colspan="2" style="text-align:center">Classification and external resources</th>
</tr>
<tr>
<th scope="row"><a href="/wiki/International_Statistical_Classification_of_Diseases_and_Related_Health_Problems" title="International Statistical Classification of Diseases and Related Health Problems">ICD</a>-<a href="/wiki/ICD-10" title="ICD-10">10</a></th>
<td><a rel="nofollow" class="external text" href="http://apps.who.int/classifications/icd10/browse/2015/en#/E71.3">E71.3</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/International_Statistical_Classification_of_Diseases_and_Related_Health_Problems" title="International Statistical Classification of Diseases and Related Health Problems">ICD</a>-<a href="/wiki/List_of_ICD-9_codes" title="List of ICD-9 codes">9-CM</a></th>
<td><a rel="nofollow" class="external text" href="http://www.icd9data.com/getICD9Code.ashx?icd9=277.85">277.85</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/OMIM" title="OMIM" class="mw-redirect">OMIM</a></th>
<td><a rel="nofollow" class="external text" href="http://omim.org/entry/255110">255110</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/Diseases_Database" title="Diseases Database">DiseasesDB</a></th>
<td><a rel="nofollow" class="external text" href="http://www.diseasesdatabase.com/ddb32534.htm">32534</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/EMedicine" title="EMedicine">eMedicine</a></th>
<td><a rel="nofollow" class="external text" href="http://www.emedicine.com/ped/topic321.htm">ped/321</a></td>
</tr>
</table>
<p><b><a href="/wiki/Carnitine_palmitoyltransferase_II" title="Carnitine palmitoyltransferase II">Carnitine palmitoyltransferase II</a> deficiency</b> (CPT-II) is an <a href="/wiki/Dominance_(genetics)" title="Dominance (genetics)">autosomal dominantly</a> inherited genetic metabolic disorder characterized by an enzymatic defect that prevents <a href="/wiki/Long-chain_fatty_acid" title="Long-chain fatty acid" class="mw-redirect">long-chain fatty acids</a> from being transported into the <a href="/wiki/Mitochondria" title="Mitochondria" class="mw-redirect">mitochondria</a> for utilization as an energy source.</p>
<p>The adult <a href="/wiki/Myopathy" title="Myopathy">myopathic</a> form of this disease was first characterized in 1973 by DiMauro and DiMauro.<sup id="cite_ref-1" class="reference"><a href="#cite_note-1"><span>[</span>1<span>]</span></a></sup> It is the most common inherited disorder of lipid metabolism affecting the <a href="/wiki/Skeletal_muscle" title="Skeletal muscle" class="mw-redirect">skeletal muscle</a> of adults.<sup id="cite_ref-corti_2-0" class="reference"><a href="#cite_note-corti-2"><span>[</span>2<span>]</span></a></sup> CPT II deficiency is also the most frequent cause of hereditary <a href="/wiki/Myoglobinuria" title="Myoglobinuria">myoglobinuria</a>.<sup id="cite_ref-gellera_3-0" class="reference"><a href="#cite_note-gellera-3"><span>[</span>3<span>]</span></a></sup> Symptoms of this disease are commonly provoked by prolonged exercise or periods without food.</p>
<p></p>
<div id="toc" class="toc">
<div id="toctitle">
<h2>Contents</h2>
</div>
<ul>
<li class="toclevel-1 tocsection-1"><a href="#Signs_and_symptoms"><span class="tocnumber">1</span> <span class="toctext">Signs and symptoms</span></a>
<ul>
<li class="toclevel-2 tocsection-2"><a href="#Adult_form"><span class="tocnumber">1.1</span> <span class="toctext">Adult form</span></a></li>
<li class="toclevel-2 tocsection-3"><a href="#Infantile_form"><span class="tocnumber">1.2</span> <span class="toctext">Infantile form</span></a></li>
<li class="toclevel-2 tocsection-4"><a href="#Neonatal_form"><span class="tocnumber">1.3</span> <span class="toctext">Neonatal form</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-5"><a href="#Biochemistry"><span class="tocnumber">2</span> <span class="toctext">Biochemistry</span></a>
<ul>
<li class="toclevel-2 tocsection-6"><a href="#Enzyme_structure"><span class="tocnumber">2.1</span> <span class="toctext">Enzyme structure</span></a></li>
<li class="toclevel-2 tocsection-7"><a href="#Catalytic_mechanism"><span class="tocnumber">2.2</span> <span class="toctext">Catalytic mechanism</span></a></li>
<li class="toclevel-2 tocsection-8"><a href="#Biochemical_significance_of_disease-causing_mutations"><span class="tocnumber">2.3</span> <span class="toctext">Biochemical significance of disease-causing mutations</span></a></li>
<li class="toclevel-2 tocsection-9"><a href="#Enzyme_activity_and_disease_severity"><span class="tocnumber">2.4</span> <span class="toctext">Enzyme activity and disease severity</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-10"><a href="#Pathophysiology"><span class="tocnumber">3</span> <span class="toctext">Pathophysiology</span></a>
<ul>
<li class="toclevel-2 tocsection-11"><a href="#Molecular_genetics"><span class="tocnumber">3.1</span> <span class="toctext">Molecular genetics</span></a>
<ul>
<li class="toclevel-3 tocsection-12"><a href="#Amino_acid_consequences_of_some_reported_mutations"><span class="tocnumber">3.1.1</span> <span class="toctext">Amino acid consequences of some reported mutations</span></a></li>
</ul>
</li>
</ul>
</li>
<li class="toclevel-1 tocsection-13"><a href="#Diagnosis"><span class="tocnumber">4</span> <span class="toctext">Diagnosis</span></a></li>
<li class="toclevel-1 tocsection-14"><a href="#Treatment"><span class="tocnumber">5</span> <span class="toctext">Treatment</span></a></li>
<li class="toclevel-1 tocsection-15"><a href="#See_also"><span class="tocnumber">6</span> <span class="toctext">See also</span></a></li>
<li class="toclevel-1 tocsection-16"><a href="#External_links"><span class="tocnumber">7</span> <span class="toctext">External links</span></a></li>
<li class="toclevel-1 tocsection-17"><a href="#References"><span class="tocnumber">8</span> <span class="toctext">References</span></a></li>
</ul>
</div>
<p></p>
<h2><span class="mw-headline" id="Signs_and_symptoms">Signs and symptoms</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Carnitine_palmitoyltransferase_II_deficiency&amp;action=edit&amp;section=1" title="Edit section: Signs and symptoms">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>There are three main types of carnitine palmitoyltransferase II deficiency classified on the basis of tissue-specific symptomotology and age of onset:<sup id="cite_ref-cptot_4-0" class="reference"><a href="#cite_note-cptot-4"><span>[</span>4<span>]</span></a></sup></p>
<ul>
<li>Mild to severe adult <a href="/wiki/Myopathic" title="Myopathic" class="mw-redirect">myopathic</a> form</li>
<li>Severe infantile multisystemic form</li>
<li>Lethal <a href="/wiki/Neonatal" title="Neonatal" class="mw-redirect">neonatal</a> form</li>
</ul>
<h3><span class="mw-headline" id="Adult_form">Adult form</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Carnitine_palmitoyltransferase_II_deficiency&amp;action=edit&amp;section=2" title="Edit section: Adult form">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>This exclusively myopathic form is the most prevalent and least severe phenotypic presentation of this disorder.<sup id="cite_ref-cptot_4-1" class="reference"><a href="#cite_note-cptot-4"><span>[</span>4<span>]</span></a></sup> Characteristic signs and symptoms include <a href="/wiki/Rhabdomyolysis" title="Rhabdomyolysis">rhabdomyolysis</a> (breakdown of muscle fibers and subsequent release of myoglobin),<sup id="cite_ref-cptcbm_5-0" class="reference"><a href="#cite_note-cptcbm-5"><span>[</span>5<span>]</span></a></sup> <a href="/wiki/Myoglobinuria" title="Myoglobinuria">myoglobinuria</a>, recurrent <a href="/wiki/Myalgia" title="Myalgia">muscle pain</a>, and weakness. It is important to note that muscle weakness and pain typically resolves within hours to days, and patients appear clinically normal in the intervening periods between attacks.<sup id="cite_ref-cptot_4-2" class="reference"><a href="#cite_note-cptot-4"><span>[</span>4<span>]</span></a></sup> Symptoms are most often exercise-induced, but fasting, a high-fat diet, exposure to cold temperature, or infection (especially febrile illness) can also provoke this metabolic myopathy.<sup id="cite_ref-cptot_4-3" class="reference"><a href="#cite_note-cptot-4"><span>[</span>4<span>]</span></a></sup><sup id="cite_ref-cptcbm_5-1" class="reference"><a href="#cite_note-cptcbm-5"><span>[</span>5<span>]</span></a></sup> In a minority of cases, disease severity can be exacerbated by three life-threatening complications resulting from persistent rhabdomyolysis: acute <a href="/wiki/Kidney_failure" title="Kidney failure" class="mw-redirect">kidney failure</a>, respiratory insufficiency, and episodic abnormal heart rhythms. Severe forms may have continual pain from general life activity.<sup id="cite_ref-cptot_4-4" class="reference"><a href="#cite_note-cptot-4"><span>[</span>4<span>]</span></a></sup> The adult form has a variable age of onset. The first appearance of symptoms usually occurs between 6 and 20 years of age but has been documented in patients as young as 8 months as well as in adults over the age of 50. roughly 80% cases reported to date have been male.<sup id="cite_ref-cptot_4-5" class="reference"><a href="#cite_note-cptot-4"><span>[</span>4<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Infantile_form">Infantile form</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Carnitine_palmitoyltransferase_II_deficiency&amp;action=edit&amp;section=3" title="Edit section: Infantile form">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Symptomatic presentation usually occurs between 6 and 24 months of age, but the majority of cases have been documented in children less than 1 year of age.<sup id="cite_ref-cptot_4-6" class="reference"><a href="#cite_note-cptot-4"><span>[</span>4<span>]</span></a></sup> The infantile form involves multiple organ systems and is primarily characterized by <a href="/w/index.php?title=Hypoketotic_hypoglycemia&amp;action=edit&amp;redlink=1" class="new" title="Hypoketotic hypoglycemia (page does not exist)">hypoketotic hypoglycemia</a> (recurring attacks of abnormally low levels of fat breakdown products and blood sugar) that often results in loss of consciousness and seizure activity.<sup id="cite_ref-cptot_4-7" class="reference"><a href="#cite_note-cptot-4"><span>[</span>4<span>]</span></a></sup> Acute liver failure, <a href="/wiki/Hepatomegaly" title="Hepatomegaly">liver enlargement</a>, and <a href="/wiki/Cardiomyopathy" title="Cardiomyopathy">cardiomyopathy</a> are also associated with the infantile presentation of this disorder. Episodes are triggered by febrile illness, infection, or fasting.<sup id="cite_ref-cptcbm_5-2" class="reference"><a href="#cite_note-cptcbm-5"><span>[</span>5<span>]</span></a></sup> Some cases of <a href="/wiki/Sudden_infant_death_syndrome" title="Sudden infant death syndrome">sudden infant death syndrome</a> are attributed to infantile CPT II deficiency at autopsy.<sup id="cite_ref-cptot_4-8" class="reference"><a href="#cite_note-cptot-4"><span>[</span>4<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Neonatal_form">Neonatal form</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Carnitine_palmitoyltransferase_II_deficiency&amp;action=edit&amp;section=4" title="Edit section: Neonatal form">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>The neonatal form is the least common clinical presentation of this disorder and is almost invariably fatal in rapid fashion regardless of intervention.<sup id="cite_ref-cptcbm_5-3" class="reference"><a href="#cite_note-cptcbm-5"><span>[</span>5<span>]</span></a></sup><sup id="cite_ref-dct_6-0" class="reference"><a href="#cite_note-dct-6"><span>[</span>6<span>]</span></a></sup> Symptomatic onset has been documented just hours after birth to within 4 days of life.<sup id="cite_ref-cptot_4-9" class="reference"><a href="#cite_note-cptot-4"><span>[</span>4<span>]</span></a></sup> Affected newborns typically experience respiratory failure, <a href="/wiki/Hypoglycemia" title="Hypoglycemia">low blood sugar</a>, <a href="/wiki/Seizure" title="Seizure" class="mw-redirect">seizures</a>, liver enlargement, liver failure, and <a href="/wiki/Cardiomegaly" title="Cardiomegaly">heart enlargement</a> with <a href="/wiki/Arrhythmia" title="Arrhythmia" class="mw-redirect">abnormal heart rhythms</a> leading to <a href="/wiki/Cardiac_arrest" title="Cardiac arrest">cardiac arrest</a>.<sup id="cite_ref-dct_6-1" class="reference"><a href="#cite_note-dct-6"><span>[</span>6<span>]</span></a></sup> In most cases, elements of abnormal brain and kidney development are apparent, sometimes even at prenatal ultrasound.<sup id="cite_ref-7" class="reference"><a href="#cite_note-7"><span>[</span>7<span>]</span></a></sup> Neuronal migration defects have also been documented, to which the CNS pathology of the disorder is often attributed.<sup id="cite_ref-dct_6-2" class="reference"><a href="#cite_note-dct-6"><span>[</span>6<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Biochemistry">Biochemistry</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Carnitine_palmitoyltransferase_II_deficiency&amp;action=edit&amp;section=5" title="Edit section: Biochemistry">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<h3><span class="mw-headline" id="Enzyme_structure">Enzyme structure</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Carnitine_palmitoyltransferase_II_deficiency&amp;action=edit&amp;section=6" title="Edit section: Enzyme structure">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>CPT II shares structural elements with other members of the carnitine acyltransferase protein family.<sup id="cite_ref-isackson_8-0" class="reference"><a href="#cite_note-isackson-8"><span>[</span>8<span>]</span></a></sup> The crystal structure of rat CPT II was recently elucidated by Hsiao et al.<sup id="cite_ref-rat_9-0" class="reference"><a href="#cite_note-rat-9"><span>[</span>9<span>]</span></a></sup> The human homolog of the CPT II enzyme shows 82.2% amino acid sequence homology with the rat protein.<sup id="cite_ref-10" class="reference"><a href="#cite_note-10"><span>[</span>10<span>]</span></a></sup> Significant structural and functional information about CPT II has thus been derived from the crystallographic studies with the rat protein.</p>
<p>In addition to similarities shared by the acyltransferases, CPT II also contains a distinct insertion of 30 residues in the amino domain that forms a relatively hydrophobic protrusion composed of two alpha helices and a small anti-parallel beta sheet.<sup id="cite_ref-rat_9-1" class="reference"><a href="#cite_note-rat-9"><span>[</span>9<span>]</span></a></sup> It has been proposed that this segment mediates the association of CPT II with the inner mitochondrial membrane.<sup id="cite_ref-rat_9-2" class="reference"><a href="#cite_note-rat-9"><span>[</span>9<span>]</span></a></sup> Moreover, the insert might also facilitate the shuttling of palmitoylcarnitines directly into the active site of CPT II after translocation across the inner membrane by virtue of its juxtaposition to the active site tunnel of the enzyme.<sup id="cite_ref-rat_9-3" class="reference"><a href="#cite_note-rat-9"><span>[</span>9<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Catalytic_mechanism">Catalytic mechanism</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Carnitine_palmitoyltransferase_II_deficiency&amp;action=edit&amp;section=7" title="Edit section: Catalytic mechanism">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>CPT II catalyzes the formation of palmitoyl-CoA from palmitoylcarnitine imported into the matrix via the acylcarnitine translocase. The catalytic core of the CPT II enzyme contains three important binding sites that recognize structural aspects of CoA, palmitoyl, and carnitine.<sup id="cite_ref-nic_11-0" class="reference"><a href="#cite_note-nic-11"><span>[</span>11<span>]</span></a></sup></p>
<p>Although kinetic studies are hindered by high substrate inhibition, strong product inhibition, very low Km values for the acyl-CoA substrates, and complex detergent effects with respect to <a href="/wiki/Micelle" title="Micelle">micelle</a> formation,<sup id="cite_ref-nic_11-1" class="reference"><a href="#cite_note-nic-11"><span>[</span>11<span>]</span></a></sup> studies have shown that CPT II demonstrates a compulsory-order mechanism in which the enzyme must bind CoA before palmitoylcarnitine, and then the resulting product palmitoyl-CoA is the last substrate to be released from the enzyme. The carnitine binding site is made accessible by the conformational change induced in the enzyme by the binding of CoA.<sup id="cite_ref-nic_11-2" class="reference"><a href="#cite_note-nic-11"><span>[</span>11<span>]</span></a></sup> This ordered mechanism is believed to be important so that the enzyme responds appropriately to the acylation state of the mitochondrial pool of CoA despite the fact that the concentrations of both CoA and acyl-CoA found in the matrix well exceed the measured km value of the enzyme (most CPT II will already have bound the CoA).<sup id="cite_ref-ramsay_12-0" class="reference"><a href="#cite_note-ramsay-12"><span>[</span>12<span>]</span></a></sup></p>
<p>The histidine residue (at position 372 in CPT II) is fully conserved in all members of the carnitine acyltransferase family and has been localized to the enzyme active site, likely playing a direct role in the catalytic mechanism of the enzyme.<sup id="cite_ref-isackson_8-1" class="reference"><a href="#cite_note-isackson-8"><span>[</span>8<span>]</span></a></sup> A general mechanism for this reaction is believed to involve this histidine acting as a general base. More specifically, this reaction proceeds as a general base-catalyzed nucleophilic attack of the thioester of acetyl-CoA by the hydroxyl group of carnitine.<sup id="cite_ref-13" class="reference"><a href="#cite_note-13"><span>[</span>13<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Biochemical_significance_of_disease-causing_mutations">Biochemical significance of disease-causing mutations</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Carnitine_palmitoyltransferase_II_deficiency&amp;action=edit&amp;section=8" title="Edit section: Biochemical significance of disease-causing mutations">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>The majority of the genetic abnormalities in CPT II deficient patients affect amino acid residues somewhat removed from the active site of the enzyme. Thus, these mutations are thought to compromise the stability of the protein rather than the catalytic activity of the enzyme.<sup id="cite_ref-rat_9-4" class="reference"><a href="#cite_note-rat-9"><span>[</span>9<span>]</span></a></sup> Theories regarding the biochemical significance of the two most common mutations are noted below:</p>
<ul>
<li><b>Ser113Leu</b> Hsiao et al.<sup id="cite_ref-rat_9-5" class="reference"><a href="#cite_note-rat-9"><span>[</span>9<span>]</span></a></sup> theorize that this mutation may disturb the hydrogen-bonding between Ser113 and Arg 498 and the ion-pair network between Arg498 and Asp376, thereby indirectly affecting the catalytic efficiency of the His372 residue. Isackson et al.<sup id="cite_ref-isackson_8-2" class="reference"><a href="#cite_note-isackson-8"><span>[</span>8<span>]</span></a></sup> suggest that this mutation increases the thermolability of the enzyme, structurally destabilizing it. This is noteworthy in light of the fact that this mutation is associated with the exercise-induced adult form (i.e., rising core body temperature may exacerbate enzymatic defects leading to symptomatic presentation).<sup id="cite_ref-cptcbm_5-4" class="reference"><a href="#cite_note-cptcbm-5"><span>[</span>5<span>]</span></a></sup> Rufer et al. speculate that mutation of serine to the bulkier, hydrophobic leucine alters a critical interaction with nearby Phe117, ultimately modifying the position and environment of the catalytically important residues Trp116 and Arg498, reducing enzyme activity.<sup id="cite_ref-rufer_14-0" class="reference"><a href="#cite_note-rufer-14"><span>[</span>14<span>]</span></a></sup></li>
</ul>
<ul>
<li><b>Pro50His</b> This proline is 23 residues from the active site, and is located right below the hydrophobic membrane insert in the active CPT II enzyme.<sup id="cite_ref-rat_9-6" class="reference"><a href="#cite_note-rat-9"><span>[</span>9<span>]</span></a></sup> Hsiao et al. speculate that this mutation indirectly compromises the association between CPT II and the inner mitochondrial membrane and disturbs the shuttling of the palmitoylcarnitine substrate into the active site of the enzyme.<sup id="cite_ref-rat_9-7" class="reference"><a href="#cite_note-rat-9"><span>[</span>9<span>]</span></a></sup></li>
</ul>
<h3><span class="mw-headline" id="Enzyme_activity_and_disease_severity">Enzyme activity and disease severity</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Carnitine_palmitoyltransferase_II_deficiency&amp;action=edit&amp;section=9" title="Edit section: Enzyme activity and disease severity">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>The clinical significance of the biochemical consequences that result from the genetic abnormalities in patients with CPT II Deficiency is a contested issue. Rufer et al. support the theory that there is an association between level of enzyme activity and clinical presentation.<sup id="cite_ref-rufer_14-1" class="reference"><a href="#cite_note-rufer-14"><span>[</span>14<span>]</span></a></sup> Multiple research groups have transfected COS-1 cells with different CPT II mutations and found varying levels of reduction in enzyme activity compared with controls: Phe352Cys reduced enzyme activity to 70% of wild-type, Ser113Leu reduced enzyme activity to 34% of wild-type, and several severe mutations reduced activity to 5-10% of wild-type.<sup id="cite_ref-isackson_8-3" class="reference"><a href="#cite_note-isackson-8"><span>[</span>8<span>]</span></a></sup></p>
<p>However, most researchers are reluctant to accept the existence of a causal relationship between enzyme functionality and clinical phenotype.<sup id="cite_ref-isackson_8-4" class="reference"><a href="#cite_note-isackson-8"><span>[</span>8<span>]</span></a></sup> Two groups<sup id="cite_ref-corti_2-1" class="reference"><a href="#cite_note-corti-2"><span>[</span>2<span>]</span></a></sup><sup id="cite_ref-15" class="reference"><a href="#cite_note-15"><span>[</span>15<span>]</span></a></sup> have recently reported a limited correlation (lacking in statistical significance) between the genotypic array and the clinical severity of the phenotype in their patient cohorts. There is a need for further explorations of this topic in order to fully assess the biochemical ramifications of this enzymatic deficiency.</p>
<p>The rate of long-chain fatty acid oxidation in CPT II-deficient patients has been proposed to be a stronger predictor of clinical severity than residual CPT II enzyme activity. For example, one study found that although the level of residual CPT II activity in adult versus infantile onset groups overlapped, a significant decrease in palmitate oxidation was noted in the infantile group when compared to the adult group.<sup id="cite_ref-thuillier_16-0" class="reference"><a href="#cite_note-thuillier-16"><span>[</span>16<span>]</span></a></sup> This group concluded that both the type and location of <i>CPT2</i> mutation in combination with at least one secondary genetic factor modulate the long-chain fatty acid flux and, therefore, the severity of the disease.<sup id="cite_ref-thuillier_16-1" class="reference"><a href="#cite_note-thuillier-16"><span>[</span>16<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Pathophysiology">Pathophysiology</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Carnitine_palmitoyltransferase_II_deficiency&amp;action=edit&amp;section=10" title="Edit section: Pathophysiology">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p><a href="/wiki/Carnitine" title="Carnitine">Carnitine</a> is a hydrophilic natural substance acquired mostly through dietary meats and dairy products and is used by cells to transport hydrophobic fatty acids.<sup id="cite_ref-dct_6-3" class="reference"><a href="#cite_note-dct-6"><span>[</span>6<span>]</span></a></sup> The "carnitine shuttle"<sup id="cite_ref-17" class="reference"><a href="#cite_note-17"><span>[</span>17<span>]</span></a></sup> is composed of three enzymes that utilize carnitine to facilitate the import of hydrophobic long-chain fatty acids from the cytosol into the mitochondrial matrix for the production of energy via β-oxidation.<sup id="cite_ref-18" class="reference"><a href="#cite_note-18"><span>[</span>18<span>]</span></a></sup></p>
<ul>
<li><b>Carnitine palmitoyltransferase I (CPT I)</b> is localized to the outer mitochondrial membrane and catalyzes the esterification reaction between carnitine and palmitoyl-CoA to produce palmitoylcarnitine. Three tissue-specific isoforms (liver, muscle, brain) have been identified.</li>
<li><b>Carnitine-acylcarnitine translocase (CACT)</b> is an integral inner mitochondrial membrane protein that transports palmitoylcarnitine from the intermembrane space into the matrix in exchange for a molecule of free carnitine that is subsequently moved back out of the mitochondria into the cytosol.</li>
<li><b>Carnitine palmitoyltransferase II (CPT II)</b> is a peripheral inner mitochondrial membrane protein ubiquitously found as a monomeric protein in all tissues that oxidize fatty acids.<sup id="cite_ref-cptcbm_5-5" class="reference"><a href="#cite_note-cptcbm-5"><span>[</span>5<span>]</span></a></sup> It catalyzes the transesterification of palmitoylcarnitine back into palmitoyl-CoA which is now an activated substrate for β-oxidation inside the matrix.</li>
</ul>
<p><a href="/wiki/File:Acyl-CoA_from_cytosol_to_the_mitochondrial_matrix.svg" class="image"><img alt="Acyl-CoA from cytosol to the mitochondrial matrix.svg" src="//upload.wikimedia.org/wikipedia/commons/thumb/a/a8/Acyl-CoA_from_cytosol_to_the_mitochondrial_matrix.svg/600px-Acyl-CoA_from_cytosol_to_the_mitochondrial_matrix.svg.png" width="600" height="400" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/a/a8/Acyl-CoA_from_cytosol_to_the_mitochondrial_matrix.svg/900px-Acyl-CoA_from_cytosol_to_the_mitochondrial_matrix.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/a/a8/Acyl-CoA_from_cytosol_to_the_mitochondrial_matrix.svg/1200px-Acyl-CoA_from_cytosol_to_the_mitochondrial_matrix.svg.png 2x" data-file-width="600" data-file-height="400" /></a></p>
<h3><span class="mw-headline" id="Molecular_genetics">Molecular genetics</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Carnitine_palmitoyltransferase_II_deficiency&amp;action=edit&amp;section=11" title="Edit section: Molecular genetics">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<div class="thumb tright">
<div class="thumbinner" style="width:222px;"><a href="/wiki/File:Autorecessive.svg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/3/3e/Autorecessive.svg/220px-Autorecessive.svg.png" width="220" height="257" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/3/3e/Autorecessive.svg/330px-Autorecessive.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/3/3e/Autorecessive.svg/440px-Autorecessive.svg.png 2x" data-file-width="1350" data-file-height="1580" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Autorecessive.svg" class="internal" title="Enlarge"></a></div>
Carnitine palmitoyltransferase II deficiency has an autosomal recessive pattern of inheritance.</div>
</div>
</div>
<p>CPT II deficiency has an autosomal recessive pattern of inheritance.<sup id="cite_ref-corti_2-2" class="reference"><a href="#cite_note-corti-2"><span>[</span>2<span>]</span></a></sup> <i><a href="/wiki/Carnitine_palmitoyltransferase_II" title="Carnitine palmitoyltransferase II">CPT2</a></i> is the <a href="/wiki/Gene" title="Gene">gene</a> that encodes the CPT II enzyme, and it has been mapped to chromosomal locus 1p32.<sup id="cite_ref-gellera_3-1" class="reference"><a href="#cite_note-gellera-3"><span>[</span>3<span>]</span></a></sup> This gene is composed of 5 exons that encode a protein 658 amino acids in length.<sup id="cite_ref-corti_2-3" class="reference"><a href="#cite_note-corti-2"><span>[</span>2<span>]</span></a></sup> To date, sixty disease-causing mutations within the coding sequence of CPT2 have been reported in the literature, of which 41 are thought to result in amino acid substitutions or deletions at critical residues.<sup id="cite_ref-isackson_8-5" class="reference"><a href="#cite_note-isackson-8"><span>[</span>8<span>]</span></a></sup></p>
<h4><span class="mw-headline" id="Amino_acid_consequences_of_some_reported_mutations">Amino acid consequences of some reported mutations</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Carnitine_palmitoyltransferase_II_deficiency&amp;action=edit&amp;section=12" title="Edit section: Amino acid consequences of some reported mutations">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<ul>
<li><b>Ser113Leu</b> (338C&gt;T) is the most common mild mutation observed in adult cases, it has an observed allelic frequency of 65% in adult cases,<sup id="cite_ref-corti_2-4" class="reference"><a href="#cite_note-corti-2"><span>[</span>2<span>]</span></a></sup> and both homozygous and heterozygous cases have been documented.</li>
<li><b>Pro50His</b> (149C&gt;A) is also relatively common in the adult form, with an allelic frequency of 6.5%.<sup id="cite_ref-cptot_4-10" class="reference"><a href="#cite_note-cptot-4"><span>[</span>4<span>]</span></a></sup></li>
<li><b>Arg161Trp</b>, <b>Glu174Lys</b> and <b>Ile502Thr</b> are other homozygous mild mutations associated with the adult form <sup id="cite_ref-isackson_8-6" class="reference"><a href="#cite_note-isackson-8"><span>[</span>8<span>]</span></a></sup></li>
<li><b>Arg151Gln</b> and <b>Pro227Leu</b> are examples of severe homozygous mutations that have been associated with the mutisystemic infantile/neonatal form of the disorder.<sup id="cite_ref-isackson_8-7" class="reference"><a href="#cite_note-isackson-8"><span>[</span>8<span>]</span></a></sup></li>
<li>The 18 known severe mutations that result in prematurely truncated proteins lack residual CPT II activity are associated with the neonatal onset and are likely incompatible with life in most circumstances.<sup id="cite_ref-isackson_8-8" class="reference"><a href="#cite_note-isackson-8"><span>[</span>8<span>]</span></a></sup></li>
<li><b>Val368Ile</b> and <b>Met647Val</b> are polymorphisms have been linked to CPT II deficiency.<sup id="cite_ref-isackson_8-9" class="reference"><a href="#cite_note-isackson-8"><span>[</span>8<span>]</span></a></sup> These genetic abnormalities alone do not directly cause the disorder, but they seem to exacerbate the reduction in enzymatic efficiency when combined with one or more primary CPT2 mutations.<sup id="cite_ref-cptot_4-11" class="reference"><a href="#cite_note-cptot-4"><span>[</span>4<span>]</span></a></sup></li>
</ul>
<p>Recent research<sup id="cite_ref-thuillier_16-2" class="reference"><a href="#cite_note-thuillier-16"><span>[</span>16<span>]</span></a></sup> found that mutations associated with a specific disease phenotype segregated to specific exons. In this study, infantile-onset cases had mutations in exon 4 or 5 of the CPT2 gene, while adult-onset cases had at least one mutation in exon 1 and/or exon 3. This group suggested that <b>Ser113Leu</b> (exon 3) and <b>Pro50His</b> (exon 1) might confer some sort of protective advantage against the development of the severe infantile phenotype in patients predisposed to develop the adult form of the disorder, since these two mutations have never been identified in cases of compound heterozygous infantile cases.<sup id="cite_ref-thuillier_16-3" class="reference"><a href="#cite_note-thuillier-16"><span>[</span>16<span>]</span></a></sup> In support of this theory, an independent group reported two cases where mutations that have been shown to cause the infantile (<b>Arg151Gln</b>) or neonatal (<b>Arg631Cys</b>) forms when homozygous instead were associated with the milder, adult-onset phenotype when present as compound heterozygous mutations with <b>Ser113Leu</b> as the second mutation.<sup id="cite_ref-corti_2-5" class="reference"><a href="#cite_note-corti-2"><span>[</span>2<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Diagnosis">Diagnosis</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Carnitine_palmitoyltransferase_II_deficiency&amp;action=edit&amp;section=13" title="Edit section: Diagnosis">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<ul>
<li><a href="/wiki/Tandem_mass_spectrometry" title="Tandem mass spectrometry">Tandem mass spectrometry</a>: non-invasive, rapid method; a significant peak at C16 is indicative of generalized CPT II deficiency<sup id="cite_ref-19" class="reference"><a href="#cite_note-19"><span>[</span>19<span>]</span></a></sup><sup id="cite_ref-20" class="reference"><a href="#cite_note-20"><span>[</span>20<span>]</span></a></sup></li>
<li>Enzymatic activity studies in <a href="/wiki/Fibroblast" title="Fibroblast">fibroblasts</a> and/or <a href="/wiki/Lymphocyte" title="Lymphocyte">lymphocytes</a></li>
<li>Laboratory findings: most patients have low total and free carnitine levels and high acylcarnitine:free carnitine ratios. Adult patients often have serum and/or urine screen positive for the presence of <a href="/wiki/Myoglobin" title="Myoglobin">myoglobin</a> and serum <a href="/wiki/Creatine_kinase" title="Creatine kinase">creatine kinase</a> and transaminase levels 20-400x higher than normal levels during an attack.<sup id="cite_ref-cptot_4-12" class="reference"><a href="#cite_note-cptot-4"><span>[</span>4<span>]</span></a></sup> Signs of metabolic acidosis and significant <a href="/wiki/Hyperammonemia" title="Hyperammonemia">hyperammonemia</a> have been reported in infantile and neonatal cases.<sup id="cite_ref-cptot_4-13" class="reference"><a href="#cite_note-cptot-4"><span>[</span>4<span>]</span></a></sup><sup id="cite_ref-dct_6-4" class="reference"><a href="#cite_note-dct-6"><span>[</span>6<span>]</span></a></sup></li>
</ul>
<h2><span class="mw-headline" id="Treatment">Treatment</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Carnitine_palmitoyltransferase_II_deficiency&amp;action=edit&amp;section=14" title="Edit section: Treatment">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Standard of care for treatment of CPT II deficiency commonly involves limitations on prolonged strenuous activity and the following dietary stipulations:</p>
<ul>
<li>The medium-chain fatty acid <a href="/wiki/Triheptanoin" title="Triheptanoin">triheptanoin</a> appears to be an effective therapy for adult-onset CPT II deficiency.</li>
<li>Restriction of lipid intake</li>
<li>Avoidance of fasting situations</li>
<li>Dietary modifications including replacement of long-chain with <a href="/wiki/Medium-chain_triglyceride" title="Medium-chain triglyceride">medium-chain triglycerides</a> supplemented with L-carnitine</li>
</ul>
<h2><span class="mw-headline" id="See_also">See also</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Carnitine_palmitoyltransferase_II_deficiency&amp;action=edit&amp;section=15" title="Edit section: See also">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<ul>
<li><a href="/wiki/Primary_carnitine_deficiency" title="Primary carnitine deficiency" class="mw-redirect">Primary carnitine deficiency</a></li>
<li><a href="/wiki/Carnitine_palmitoyltransferase_I_deficiency" title="Carnitine palmitoyltransferase I deficiency">Carnitine palmitoyltransferase I deficiency</a></li>
<li><a href="/wiki/Carnitine_O-palmitoyltransferase" title="Carnitine O-palmitoyltransferase">Carnitine O-palmitoyltransferase</a></li>
<li><a href="/wiki/Fasciculation" title="Fasciculation">Fasciculation</a></li>
<li><a href="/wiki/Myokymia" title="Myokymia">Myokymia</a></li>
</ul>
<h2><span class="mw-headline" id="External_links">External links</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Carnitine_palmitoyltransferase_II_deficiency&amp;action=edit&amp;section=16" title="Edit section: External links">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p><i>This article incorporates public domain text from <a rel="nofollow" class="external text" href="http://ghr.nlm.nih.gov">The U.S. National Library of Medicine</a></i></p>
<ul>
<li><a rel="nofollow" class="external text" href="http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&amp;part=cpt2">GeneReviews/NCBI/NIH/UW entry on Carnitine Palmitoyltransferase II Deficiency</a></li>
</ul>
<h2><span class="mw-headline" id="References">References</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Carnitine_palmitoyltransferase_II_deficiency&amp;action=edit&amp;section=17" title="Edit section: References">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="reflist columns references-column-count references-column-count-2" style="-moz-column-count: 2; -webkit-column-count: 2; column-count: 2; list-style-type: decimal;">
<ol class="references">
<li id="cite_note-1"><span class="mw-cite-backlink"><b><a href="#cite_ref-1">^</a></b></span> <span class="reference-text"><span class="citation journal">DiMauro S, DiMauro PMM (1973). "Muscle carnitine palmitoyltransferase deficiency and myoglobinuria". <i>Science</i> <b>182</b> (4115): 929–931. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1126%2Fscience.182.4115.929">10.1126/science.182.4115.929</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/4745596">4745596</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACarnitine+palmitoyltransferase+II+deficiency&amp;rft.atitle=Muscle+carnitine+palmitoyltransferase+deficiency+and+myoglobinuria&amp;rft.au=DiMauro+S%2C+DiMauro+PMM&amp;rft.aulast=DiMauro+S%2C+DiMauro+PMM&amp;rft.date=1973&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1126%2Fscience.182.4115.929&amp;rft_id=info%3Apmid%2F4745596&amp;rft.issue=4115&amp;rft.jtitle=Science&amp;rft.pages=929-931&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=182" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-corti-2"><span class="mw-cite-backlink">^ <a href="#cite_ref-corti_2-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-corti_2-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-corti_2-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-corti_2-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-corti_2-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-corti_2-5"><sup><i><b>f</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Corti S, Bordoni A, Ronchi D et al. (March 2008). "Clinical features and new molecular findings in Carnitine Palmitoyltransferase II (CPT II) deficiency". <i>Journal of the Neurological Sciences</i> <b>266</b> (1-2): 97–103. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fj.jns.2007.09.015">10.1016/j.jns.2007.09.015</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17936304">17936304</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACarnitine+palmitoyltransferase+II+deficiency&amp;rft.atitle=Clinical+features+and+new+molecular+findings+in+Carnitine+Palmitoyltransferase+II+%28CPT+II%29+deficiency&amp;rft.au=Corti+S%2C+Bordoni+A%2C+Ronchi+D&amp;rft.aulast=Corti+S%2C+Bordoni+A%2C+Ronchi+D&amp;rft.date=March+2008&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.jns.2007.09.015&amp;rft_id=info%3Apmid%2F17936304&amp;rft.issue=1-2&amp;rft.jtitle=Journal+of+the+Neurological+Sciences&amp;rft.pages=97-103&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=266" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-gellera-3"><span class="mw-cite-backlink">^ <a href="#cite_ref-gellera_3-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-gellera_3-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Gellera C et al. (1994). "Assignment of the human carnitine palmitoyltransferase II gene (CPT1) to chromosome 1p32". <i>Genomics</i> <b>24</b> (1): 195–7. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1006%2Fgeno.1994.1605">10.1006/geno.1994.1605</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/7896283">7896283</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACarnitine+palmitoyltransferase+II+deficiency&amp;rft.atitle=Assignment+of+the+human+carnitine+palmitoyltransferase+II+gene+%28CPT1%29+to+chromosome+1p32&amp;rft.au=Gellera+C&amp;rft.aulast=Gellera+C&amp;rft.date=1994&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1006%2Fgeno.1994.1605&amp;rft_id=info%3Apmid%2F7896283&amp;rft.issue=1&amp;rft.jtitle=Genomics&amp;rft.pages=195-7&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=24" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-cptot-4"><span class="mw-cite-backlink">^ <a href="#cite_ref-cptot_4-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-cptot_4-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-cptot_4-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-cptot_4-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-cptot_4-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-cptot_4-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-cptot_4-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-cptot_4-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-cptot_4-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-cptot_4-9"><sup><i><b>j</b></i></sup></a> <a href="#cite_ref-cptot_4-10"><sup><i><b>k</b></i></sup></a> <a href="#cite_ref-cptot_4-11"><sup><i><b>l</b></i></sup></a> <a href="#cite_ref-cptot_4-12"><sup><i><b>m</b></i></sup></a> <a href="#cite_ref-cptot_4-13"><sup><i><b>n</b></i></sup></a></span> <span class="reference-text">Bonnefont JP et al. (2004). Carnitine palmitoyltransferases 1 and 2: biochemical, molecular and medical aspects. Molec Aspects Med, 25(5-6): 495-520. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fj.mam.2004.06.004">10.1016/j.mam.2004.06.004</a> <a class="external mw-magiclink-pmid" rel="nofollow" href="//www.ncbi.nlm.nih.gov/pubmed/15363638?dopt=Abstract">PMID 15363638</a></span></li>
<li id="cite_note-cptcbm-5"><span class="mw-cite-backlink">^ <a href="#cite_ref-cptcbm_5-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-cptcbm_5-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-cptcbm_5-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-cptcbm_5-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-cptcbm_5-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-cptcbm_5-5"><sup><i><b>f</b></i></sup></a></span> <span class="reference-text">Sigauke E et al. (2003). Carnitine Palmitoyltransferase II Deficiency: A Clinical, Biochemical, and Molecular Review. Laboratory Invest, 83(11): 1543-54. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1097%2F01.LAB.0000098428.51765.83">10.1097/01.LAB.0000098428.51765.83</a> <a class="external mw-magiclink-pmid" rel="nofollow" href="//www.ncbi.nlm.nih.gov/pubmed/14615409?dopt=Abstract">PMID 14615409</a></span></li>
<li id="cite_note-dct-6"><span class="mw-cite-backlink">^ <a href="#cite_ref-dct_6-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-dct_6-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-dct_6-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-dct_6-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-dct_6-4"><sup><i><b>e</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Longo N, Amat , San Filippo C, Pasquali M (2006). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2557099">"Disorders of Carnitine Transport and the Carnitine Cycle"</a>. <i>Am J Med Genet C Semin Med Genet</i> <b>142</b> (2): 77–85. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1002%2Fajmg.c.30087">10.1002/ajmg.c.30087</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2557099">2557099</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16602102">16602102</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACarnitine+palmitoyltransferase+II+deficiency&amp;rft.atitle=Disorders+of+Carnitine+Transport+and+the+Carnitine+Cycle&amp;rft.aulast=Longo+N%2C+Amat+%2C+San+Filippo+C%2C+Pasquali+M&amp;rft.au=Longo+N%2C+Amat+%2C+San+Filippo+C%2C+Pasquali+M&amp;rft.date=2006&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2557099&amp;rft_id=info%3Adoi%2F10.1002%2Fajmg.c.30087&amp;rft_id=info%3Apmc%2F2557099&amp;rft_id=info%3Apmid%2F16602102&amp;rft.issue=2&amp;rft.jtitle=Am+J+Med+Genet+C+Semin+Med+Genet&amp;rft.pages=77-85&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=142" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-7"><span class="mw-cite-backlink"><b><a href="#cite_ref-7">^</a></b></span> <span class="reference-text"><span class="citation journal">Sharma R, Perszyk AA, Marangi D, Monteiro C, Raja S (January 2003). "Lethal neonatal carnitine palmitoyltransferase II deficiency: an unusual presentation of a rare disorder". <i>American Journal of Perinatology</i> <b>20</b> (1): 25–32. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1055%2Fs-2003-37952">10.1055/s-2003-37952</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/12638078">12638078</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACarnitine+palmitoyltransferase+II+deficiency&amp;rft.atitle=Lethal+neonatal+carnitine+palmitoyltransferase+II+deficiency%3A+an+unusual+presentation+of+a+rare+disorder&amp;rft.aulast=Sharma+R%2C+Perszyk+AA%2C+Marangi+D%2C+Monteiro+C%2C+Raja+S&amp;rft.au=Sharma+R%2C+Perszyk+AA%2C+Marangi+D%2C+Monteiro+C%2C+Raja+S&amp;rft.date=January+2003&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1055%2Fs-2003-37952&amp;rft_id=info%3Apmid%2F12638078&amp;rft.issue=1&amp;rft.jtitle=American+Journal+of+Perinatology&amp;rft.pages=25-32&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=20" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-isackson-8"><span class="mw-cite-backlink">^ <a href="#cite_ref-isackson_8-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-isackson_8-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-isackson_8-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-isackson_8-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-isackson_8-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-isackson_8-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-isackson_8-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-isackson_8-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-isackson_8-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-isackson_8-9"><sup><i><b>j</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Isackson PJ, Bennett MJ, Vladutiu GD (December 2006). "Identification of 16 new disease-causing mutations in the CPT2 gene resulting in carnitine palmitoyltransferase II deficiency". <i>Molecular Genetics and Metabolism</i> <b>89</b> (4): 323–31. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fj.ymgme.2006.08.004">10.1016/j.ymgme.2006.08.004</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16996287">16996287</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACarnitine+palmitoyltransferase+II+deficiency&amp;rft.atitle=Identification+of+16+new+disease-causing+mutations+in+the+CPT2+gene+resulting+in+carnitine+palmitoyltransferase+II+deficiency&amp;rft.au=Isackson+PJ%2C+Bennett+MJ%2C+Vladutiu+GD&amp;rft.aulast=Isackson+PJ%2C+Bennett+MJ%2C+Vladutiu+GD&amp;rft.date=December+2006&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.ymgme.2006.08.004&amp;rft_id=info%3Apmid%2F16996287&amp;rft.issue=4&amp;rft.jtitle=Molecular+Genetics+and+Metabolism&amp;rft.pages=323-31&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=89" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-rat-9"><span class="mw-cite-backlink">^ <a href="#cite_ref-rat_9-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-rat_9-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-rat_9-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-rat_9-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-rat_9-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-rat_9-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-rat_9-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-rat_9-7"><sup><i><b>h</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Hsiao Y, Jogl G, Esser V, Tong L (2006). "Crystal structure of rat carnitine palmitoyltransferase II (CPT-II)". <i>Biochem Biophys Res Commun</i> <b>346</b> (3): 974–80. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fj.bbrc.2006.06.006">10.1016/j.bbrc.2006.06.006</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACarnitine+palmitoyltransferase+II+deficiency&amp;rft.atitle=Crystal+structure+of+rat+carnitine+palmitoyltransferase+II+%28CPT-II%29&amp;rft.au=Hsiao+Y%2C+Jogl+G%2C+Esser+V%2C+Tong+L&amp;rft.aulast=Hsiao+Y%2C+Jogl+G%2C+Esser+V%2C+Tong+L&amp;rft.date=2006&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.bbrc.2006.06.006&amp;rft.issue=3&amp;rft.jtitle=Biochem+Biophys+Res+Commun&amp;rft.pages=974-80&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=346" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-10"><span class="mw-cite-backlink"><b><a href="#cite_ref-10">^</a></b></span> <span class="reference-text"><span class="citation journal">Finocchiaro G et al. (1991). "cDNA cloning, sequence analysis, and chromosomal localization of the gene for human carnitine palmitoyltransferase". <i>Proc Natl Acad Sci</i> <b>88</b> (2): 661–5. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1073%2Fpnas.88.2.661">10.1073/pnas.88.2.661</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACarnitine+palmitoyltransferase+II+deficiency&amp;rft.atitle=cDNA+cloning%2C+sequence+analysis%2C+and+chromosomal+localization+of+the+gene+for+human+carnitine+palmitoyltransferase&amp;rft.au=Finocchiaro+G&amp;rft.aulast=Finocchiaro+G&amp;rft.date=1991&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1073%2Fpnas.88.2.661&amp;rft.issue=2&amp;rft.jtitle=Proc+Natl+Acad+Sci&amp;rft.pages=661-5&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=88" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-nic-11"><span class="mw-cite-backlink">^ <a href="#cite_ref-nic_11-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-nic_11-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-nic_11-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Nic , Bhaird N et al. (1993). "Comparison of the active sites of the purified carnitine acyltransferases from peroxisomes and mitochondria by using a reaction-intermediate analogue". <i>Biochem J</i> <b>294</b>: 645–51.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACarnitine+palmitoyltransferase+II+deficiency&amp;rft.atitle=Comparison+of+the+active+sites+of+the+purified+carnitine+acyltransferases+from+peroxisomes+and+mitochondria+by+using+a+reaction-intermediate+analogue&amp;rft.aulast=Nic+%2C+Bhaird+N&amp;rft.au=Nic+%2C+Bhaird+N&amp;rft.date=1993&amp;rft.genre=article&amp;rft.jtitle=Biochem+J&amp;rft.pages=645-51&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=294" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-ramsay-12"><span class="mw-cite-backlink"><b><a href="#cite_ref-ramsay_12-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Ramsay R et al. (2001). "Molecular enzymology of carnitine transfer and transport". <i>Biochim Biophys Acta: Protein Structure and Molecular Enzymology</i> <b>1546</b>: 21–43. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fs0167-4838%2801%2900147-9">10.1016/s0167-4838(01)00147-9</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACarnitine+palmitoyltransferase+II+deficiency&amp;rft.atitle=Molecular+enzymology+of+carnitine+transfer+and+transport&amp;rft.aulast=Ramsay+R&amp;rft.au=Ramsay+R&amp;rft.date=2001&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fs0167-4838%2801%2900147-9&amp;rft.jtitle=Biochim+Biophys+Acta%3A+Protein+Structure+and+Molecular+Enzymology&amp;rft.pages=21-43&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=1546" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-13"><span class="mw-cite-backlink"><b><a href="#cite_ref-13">^</a></b></span> <span class="reference-text"><span class="citation journal">Wu D et al. (2003). "Structure of Human Carnitine Acetyltransferase: Molecular Basis For Fatty Acyl Transfer". <i>J Biol Chem</i> <b>278</b> (15): 13159–65. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1074%2Fjbc.m212356200">10.1074/jbc.m212356200</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACarnitine+palmitoyltransferase+II+deficiency&amp;rft.atitle=Structure+of+Human+Carnitine+Acetyltransferase%3A+Molecular+Basis+For+Fatty+Acyl+Transfer&amp;rft.aulast=Wu+D&amp;rft.au=Wu+D&amp;rft.date=2003&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1074%2Fjbc.m212356200&amp;rft.issue=15&amp;rft.jtitle=J+Biol+Chem&amp;rft.pages=13159-65&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=278" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-rufer-14"><span class="mw-cite-backlink">^ <a href="#cite_ref-rufer_14-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-rufer_14-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Rufer A et al. (2006). "The Crystal Structure of Carnitine Palmitoyltransferase 2 and Implications for Diabetes Treatment". <i>Structure</i> <b>14</b>: 713–23. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fj.str.2006.01.008">10.1016/j.str.2006.01.008</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACarnitine+palmitoyltransferase+II+deficiency&amp;rft.atitle=The+Crystal+Structure+of+Carnitine+Palmitoyltransferase+2+and+Implications+for+Diabetes+Treatment&amp;rft.aulast=Rufer+A&amp;rft.au=Rufer+A&amp;rft.date=2006&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.str.2006.01.008&amp;rft.jtitle=Structure&amp;rft.pages=713-23&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=14" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-15"><span class="mw-cite-backlink"><b><a href="#cite_ref-15">^</a></b></span> <span class="reference-text"><span class="citation journal">Wieser T et al. (2003). "Carnitine palmitoyltransferase II deficiency: molecular and biochemical analysis of 32 patients". <i>Neurology</i> <b>60</b> (8): 1351–3. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1212%2F01.wnl.0000055901.58642.48">10.1212/01.wnl.0000055901.58642.48</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACarnitine+palmitoyltransferase+II+deficiency&amp;rft.atitle=Carnitine+palmitoyltransferase+II+deficiency%3A+molecular+and+biochemical+analysis+of+32+patients&amp;rft.aulast=Wieser+T&amp;rft.au=Wieser+T&amp;rft.date=2003&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1212%2F01.wnl.0000055901.58642.48&amp;rft.issue=8&amp;rft.jtitle=Neurology&amp;rft.pages=1351-3&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=60" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-thuillier-16"><span class="mw-cite-backlink">^ <a href="#cite_ref-thuillier_16-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-thuillier_16-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-thuillier_16-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-thuillier_16-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text">Thuillier L et al. (2003). Correlation between genotype, metabolic data, and clinical presentation in carnitine palmitoyltransferase 2 (CPT2) deficiency. Hum Metab, 21: 493-501.</span></li>
<li id="cite_note-17"><span class="mw-cite-backlink"><b><a href="#cite_ref-17">^</a></b></span> <span class="reference-text">Nelson DL and Cox MM (2005). "Fatty Acid Catabolism" in Lehninger Principles of Biochemistry, 4th Ed. New York: W.H. Freeman and Company, 631-55.</span></li>
<li id="cite_note-18"><span class="mw-cite-backlink"><b><a href="#cite_ref-18">^</a></b></span> <span class="reference-text"><span class="citation journal">Kerner J, Hoppel C (June 2000). "Fatty acid import into mitochondria" <b>1486</b> (1). pp.&#160;1–17. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/10856709">10856709</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACarnitine+palmitoyltransferase+II+deficiency&amp;rft.au=Kerner+J%2C+Hoppel+C&amp;rft.aulast=Kerner+J%2C+Hoppel+C&amp;rft.btitle=Fatty+acid+import+into+mitochondria&amp;rft.date=June+2000&amp;rft.genre=book&amp;rft_id=info%3Apmid%2F10856709&amp;rft.issue=1&amp;rft.pages=1-17&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.volume=1486" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-19"><span class="mw-cite-backlink"><b><a href="#cite_ref-19">^</a></b></span> <span class="reference-text">Brivet M et al. (1999). Defects in activation and transport of fatty acids. J Inher Metab Dis, 22: 428-441.</span></li>
<li id="cite_note-20"><span class="mw-cite-backlink"><b><a href="#cite_ref-20">^</a></b></span> <span class="reference-text">Rettinger A et al. (2002). Tandem Mass Spectrometric Assay for the Determination of Carnitine Palmitoyltransferase II Activity in Muscle Tissue. Analyt Biochem, 302: 246-251.</span></li>
</ol>
</div>
<table class="navbox" style="border-spacing:0">
<tr>
<td style="padding:2px">
<table class="nowraplinks collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Lipid_metabolism_disorders" title="Template:Lipid metabolism disorders"><span title="View this template" style=";;background:none transparent;border:none;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Lipid_metabolism_disorders" title="Template talk:Lipid metabolism disorders"><span title="Discuss this template" style=";;background:none transparent;border:none;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Lipid_metabolism_disorders&amp;action=edit"><span title="Edit this template" style=";;background:none transparent;border:none;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%"><a href="/wiki/Inborn_error_of_metabolism" title="Inborn error of metabolism">Inborn error</a> of <a href="/wiki/Inborn_error_of_lipid_metabolism" title="Inborn error of lipid metabolism">lipid metabolism</a>: <a href="/wiki/Dyslipidemia" title="Dyslipidemia">dyslipidemia</a> (<a href="/wiki/ICD-10_Chapter_IV:_Endocrine,_nutritional_and_metabolic_diseases#.28E75.29_Lipids" title="ICD-10 Chapter IV: Endocrine, nutritional and metabolic diseases">E78</a>, <a href="/wiki/List_of_ICD-9_codes_240%E2%80%93279:_endocrine,_nutritional_and_metabolic_diseases,_and_immunity_disorders#Other_metabolic_and_immunity_disorders_.28270.E2.80.93279.29" title="List of ICD-9 codes 240–279: endocrine, nutritional and metabolic diseases, and immunity disorders">272.0–272.6</a>)</div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Hyperlipidemia" title="Hyperlipidemia">Hyperlipidemia</a></th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Hypercholesterolemia" title="Hypercholesterolemia">Hypercholesterolemia</a>/<a href="/wiki/Hypertriglyceridemia" title="Hypertriglyceridemia">Hypertriglyceridemia</a>
<ul>
<li><a href="/wiki/Lipoprotein_lipase_deficiency" title="Lipoprotein lipase deficiency">Lipoprotein lipase deficiency/Type Ia</a></li>
<li><a href="/wiki/Familial_apoprotein_CII_deficiency" title="Familial apoprotein CII deficiency" class="mw-redirect">Familial apoprotein CII deficiency/Type Ib</a></li>
<li><a href="/wiki/Familial_hypercholesterolemia" title="Familial hypercholesterolemia">Familial hypercholesterolemia/Type IIa</a></li>
<li><a href="/wiki/Combined_hyperlipidemia" title="Combined hyperlipidemia">Combined hyperlipidemia/Type IIb</a></li>
<li><a href="/wiki/Familial_dysbetalipoproteinemia" title="Familial dysbetalipoproteinemia">Familial dysbetalipoproteinemia/Type III</a></li>
<li><a href="/wiki/Familial_hypertriglyceridemia" title="Familial hypertriglyceridemia">Familial hypertriglyceridemia/Type IV</a></li>
</ul>
</li>
<li><a href="/wiki/Xanthoma" title="Xanthoma">Xanthoma/Xanthomatosis</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Hypolipoproteinemia" title="Hypolipoproteinemia">Hypolipoproteinemia</a></th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Hypoalphalipoproteinemia" title="Hypoalphalipoproteinemia">Hypoalphalipoproteinemia/HDL</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Lecithin_cholesterol_acyltransferase_deficiency" title="Lecithin cholesterol acyltransferase deficiency">Lecithin cholesterol acyltransferase deficiency</a></li>
<li><a href="/wiki/Tangier_disease" title="Tangier disease">Tangier disease</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Hypobetalipoproteinemia" title="Hypobetalipoproteinemia">Hypobetalipoproteinemia/LDL</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Abetalipoproteinemia" title="Abetalipoproteinemia">Abetalipoproteinemia</a></li>
<li><a href="/wiki/Apolipoprotein_B_deficiency" title="Apolipoprotein B deficiency">Apolipoprotein B deficiency</a></li>
<li><a href="/wiki/Chylomicron_retention_disease" title="Chylomicron retention disease">Chylomicron retention disease</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Lipodystrophy" title="Lipodystrophy">Lipodystrophy</a></th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Barraquer%E2%80%93Simons_syndrome" title="Barraquer–Simons syndrome">Barraquer–Simons syndrome</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Other</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Lipomatosis" title="Lipomatosis">Lipomatosis</a></li>
<li><a href="/wiki/Adiposis_dolorosa" title="Adiposis dolorosa">Adiposis dolorosa</a></li>
<li><a href="/wiki/Urbach%E2%80%93Wiethe_disease" title="Urbach–Wiethe disease">Lipoid proteinosis</a></li>
<li><a href="/wiki/Familial_renal_amyloidosis" title="Familial renal amyloidosis">APOA1 familial renal amyloidosis</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<td class="navbox-abovebelow" colspan="2" style="background: transparent; padding: 0px;">
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Metabolic_navs" title="Template:Metabolic navs"><span title="View this template" style=";;background:none transparent;border:none;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Metabolic_navs" title="Template talk:Metabolic navs"><span title="Discuss this template" style=";;background:none transparent;border:none;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Metabolic_navs&amp;action=edit"><span title="Edit this template" style=";;background:none transparent;border:none;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%">Index of <a href="/wiki/Inborn_error_of_metabolism" title="Inborn error of metabolism">inborn errors of metabolism</a></div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Description</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Metabolism" title="Template:Metabolism">Metabolism</a></li>
<li>Enzymes and pathways: <a href="/wiki/Template:Citric_acid_cycle" title="Template:Citric acid cycle">citric acid cycle</a>
<ul>
<li><a href="/wiki/Template:Citric_acid_cycle_enzymes_and_ETC" title="Template:Citric acid cycle enzymes and ETC">enzymes</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Pentose_phosphate_pathway_enzymes" title="Template:Pentose phosphate pathway enzymes">pentose phosphate</a>
<ul>
<li><a href="/wiki/Template:Pentose_phosphate_pathway_intermediates" title="Template:Pentose phosphate pathway intermediates">intermediates</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Glycoproteins" title="Template:Glycoproteins">glycoproteins</a>
<ul>
<li><a href="/wiki/Template:Glycoprotein_metabolism_enzymes" title="Template:Glycoprotein metabolism enzymes">enzymes</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Glycosaminoglycans" title="Template:Glycosaminoglycans">glycosaminoglycans</a>
<ul>
<li><a href="/wiki/Template:Proteoglycan_metabolism_enzymes" title="Template:Proteoglycan metabolism enzymes">proteoglycan enzymes</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Phospholipids" title="Template:Phospholipids">phospholipid</a>
<ul>
<li><a href="/wiki/Template:Phospholipid_metabolism" title="Template:Phospholipid metabolism">metabolism</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Cholesterol_and_steroid_metabolism_enzymes" title="Template:Cholesterol and steroid metabolism enzymes">cholesterol and steroid</a>
<ul>
<li><a href="/wiki/Template:Cholesterol_and_steroid_intermediates" title="Template:Cholesterol and steroid intermediates">intermediates</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Sphingolipids" title="Template:Sphingolipids">sphingolipids</a>
<ul>
<li><a href="/wiki/Template:Glycolipid/sphingolipid_metabolism_enzymes" title="Template:Glycolipid/sphingolipid metabolism enzymes" class="mw-redirect">enzymes</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Eicosanoids" title="Template:Eicosanoids">eicosanoids</a>
<ul>
<li><a href="/wiki/Template:Eicosanoid_metabolism_enzymes" title="Template:Eicosanoid metabolism enzymes">enzymes</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Amino_acid_metabolism_enzymes" title="Template:Amino acid metabolism enzymes">amino acid</a>
<ul>
<li><a href="/wiki/Template:Amino_acid_metabolism_intermediates" title="Template:Amino acid metabolism intermediates">intermediates</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Urea_cycle" title="Template:Urea cycle">urea cycle</a>
<ul>
<li><a href="/wiki/Template:Urea_cycle_enzymes" title="Template:Urea cycle enzymes">enzymes</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Nucleotide_metabolism_enzymes" title="Template:Nucleotide metabolism enzymes">nucleotide</a>
<ul>
<li><a href="/wiki/Template:Nucleotide_metabolism_intermediates" title="Template:Nucleotide metabolism intermediates">intermediates</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Disorders</th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Disorders_of_TCA_and_ETC" title="Template:Disorders of TCA and ETC">Citric acid cycle and electron transport chain</a></li>
<li><a href="/wiki/Template:Glycoprotein_disorders" title="Template:Glycoprotein disorders">Glycoprotein</a></li>
<li><a href="/wiki/Template:Proteoglycan_disorders" title="Template:Proteoglycan disorders">Proteoglycan</a></li>
<li><a href="/wiki/Template:Fatty-acid_metabolism_disorders" title="Template:Fatty-acid metabolism disorders">Fatty-acid</a></li>
<li><a href="/wiki/Template:Phospholipid_metabolism_disorders" title="Template:Phospholipid metabolism disorders">Phospholipid</a></li>
<li><a href="/wiki/Template:Defects_of_cholesterol_and_steroid_metabolism" title="Template:Defects of cholesterol and steroid metabolism">Cholesterol and steroid</a></li>
<li><a href="/wiki/Template:Eicosanoid_metabolism_disorders" title="Template:Eicosanoid metabolism disorders">Eicosanoid</a></li>
<li><a href="/wiki/Template:Amino_acid_metabolic_pathology" title="Template:Amino acid metabolic pathology">Amino acid</a></li>
<li><a href="/wiki/Template:Inborn_errors_of_purine-pyrimidine_metabolism" title="Template:Inborn errors of purine-pyrimidine metabolism">Purine-pyrimidine</a></li>
<li><a href="/wiki/Template:Heme_metabolism_disorders" title="Template:Heme metabolism disorders">Heme metabolism</a></li>
<li><a href="/wiki/Template:Eponymous_medical_signs_for_endocrinology,_nutrition,_and_metabolism" title="Template:Eponymous medical signs for endocrinology, nutrition, and metabolism">Symptoms and signs</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Treatment</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li>Drugs
<ul>
<li><a href="/wiki/Template:Other_alimentary_tract_and_metabolism_products" title="Template:Other alimentary tract and metabolism products">other</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
</table>
<table class="navbox" style="border-spacing:0">
<tr>
<td style="padding:2px">
<table class="nowraplinks collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Fatty-acid_metabolism_disorders" title="Template:Fatty-acid metabolism disorders"><span title="View this template" style=";;background:none transparent;border:none;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Fatty-acid_metabolism_disorders" title="Template talk:Fatty-acid metabolism disorders"><span title="Discuss this template" style=";;background:none transparent;border:none;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Fatty-acid_metabolism_disorders&amp;action=edit"><span title="Edit this template" style=";;background:none transparent;border:none;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%"><a href="/wiki/Inborn_error_of_metabolism" title="Inborn error of metabolism">Inborn error</a> of <a href="/wiki/Inborn_error_of_lipid_metabolism" title="Inborn error of lipid metabolism">lipid metabolism</a>: <a href="/wiki/Fatty-acid_metabolism_disorder" title="Fatty-acid metabolism disorder">fatty-acid metabolism disorders</a> (<a href="/wiki/ICD-10_Chapter_IV:_Endocrine,_nutritional_and_metabolic_diseases#.28E70.E2.80.93E72.29_Amino-acids" title="ICD-10 Chapter IV: Endocrine, nutritional and metabolic diseases">E71.3</a>, <a href="/wiki/List_of_ICD-9_codes_240%E2%80%93279:_endocrine,_nutritional_and_metabolic_diseases,_and_immunity_disorders#Other_metabolic_and_immunity_disorders_.28270.E2.80.93279.29" title="List of ICD-9 codes 240–279: endocrine, nutritional and metabolic diseases, and immunity disorders">277.81–277.85</a>)</div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Synthesis</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Biotinidase_deficiency" title="Biotinidase deficiency">Biotinidase deficiency</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Degradation</th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Fatty-acid_metabolism_disorder#Carnitine.2Ftransport" title="Fatty-acid metabolism disorder">Acyl transport</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/Carnitine" title="Carnitine">Carnitine</a></i>
<ul>
<li><a href="/wiki/Systemic_primary_carnitine_deficiency" title="Systemic primary carnitine deficiency">Primary</a></li>
<li><a href="/wiki/Carnitine_palmitoyltransferase_I_deficiency" title="Carnitine palmitoyltransferase I deficiency">I</a></li>
<li><strong class="selflink">II</strong></li>
<li><a href="/wiki/Carnitine-acylcarnitine_translocase_deficiency" title="Carnitine-acylcarnitine translocase deficiency">-acylcarnitine</a></li>
</ul>
</li>
<li><a href="/wiki/Adrenoleukodystrophy" title="Adrenoleukodystrophy">Adrenoleukodystrophy</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Beta_oxidation" title="Beta oxidation">Beta oxidation</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group">General</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/Acyl_CoA_dehydrogenase" title="Acyl CoA dehydrogenase">Acyl CoA dehydrogenase</a></i>
<ul>
<li><a href="/wiki/Short-chain_acyl-coenzyme_A_dehydrogenase_deficiency" title="Short-chain acyl-coenzyme A dehydrogenase deficiency">Short-chain</a></li>
<li><a href="/wiki/Medium-chain_acyl-coenzyme_A_dehydrogenase_deficiency" title="Medium-chain acyl-coenzyme A dehydrogenase deficiency">Medium-chain</a></li>
<li><a href="/wiki/Long-chain_3-hydroxyacyl-coenzyme_A_dehydrogenase_deficiency" title="Long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency">Long-chain 3-hydroxy</a></li>
<li><a href="/wiki/Very_long-chain_acyl-coenzyme_A_dehydrogenase_deficiency" title="Very long-chain acyl-coenzyme A dehydrogenase deficiency">Very long-chain</a></li>
</ul>
</li>
</ul>
<ul>
<li><a href="/wiki/Mitochondrial_trifunctional_protein_deficiency" title="Mitochondrial trifunctional protein deficiency">Mitochondrial trifunctional protein deficiency</a>: <a href="/wiki/Acute_fatty_liver_of_pregnancy" title="Acute fatty liver of pregnancy">Acute fatty liver of pregnancy</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Beta_oxidation#.CE.B2-Oxidation_of_unsaturated_fatty_acids" title="Beta oxidation">Unsaturated</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/2,4_Dienoyl-CoA_reductase_deficiency" title="2,4 Dienoyl-CoA reductase deficiency">2,4 Dienoyl-CoA reductase deficiency</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Beta_oxidation#.CE.B2-Oxidation_of_odd-numbered_chains" title="Beta oxidation">Odd chain</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Propionic_acidemia" title="Propionic acidemia">Propionic acidemia</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Other</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/3-hydroxyacyl-coenzyme_A_dehydrogenase_deficiency" title="3-hydroxyacyl-coenzyme A dehydrogenase deficiency">3-hydroxyacyl-coenzyme A dehydrogenase deficiency</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">To <a href="/wiki/Acetyl-CoA" title="Acetyl-CoA">acetyl-CoA</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Malonyl-CoA_decarboxylase_deficiency" title="Malonyl-CoA decarboxylase deficiency">Malonic aciduria</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Aldehyde" title="Aldehyde">Aldehyde</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Sj%C3%B6gren%E2%80%93Larsson_syndrome" title="Sjögren–Larsson syndrome">Sjögren–Larsson syndrome</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<td class="navbox-abovebelow" colspan="2" style="background: transparent; padding: 0px;">
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Metabolic_navs" title="Template:Metabolic navs"><span title="View this template" style=";;background:none transparent;border:none;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Metabolic_navs" title="Template talk:Metabolic navs"><span title="Discuss this template" style=";;background:none transparent;border:none;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Metabolic_navs&amp;action=edit"><span title="Edit this template" style=";;background:none transparent;border:none;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%">Index of <a href="/wiki/Inborn_error_of_metabolism" title="Inborn error of metabolism">inborn errors of metabolism</a></div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Description</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Metabolism" title="Template:Metabolism">Metabolism</a></li>
<li>Enzymes and pathways: <a href="/wiki/Template:Citric_acid_cycle" title="Template:Citric acid cycle">citric acid cycle</a>
<ul>
<li><a href="/wiki/Template:Citric_acid_cycle_enzymes_and_ETC" title="Template:Citric acid cycle enzymes and ETC">enzymes</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Pentose_phosphate_pathway_enzymes" title="Template:Pentose phosphate pathway enzymes">pentose phosphate</a>
<ul>
<li><a href="/wiki/Template:Pentose_phosphate_pathway_intermediates" title="Template:Pentose phosphate pathway intermediates">intermediates</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Glycoproteins" title="Template:Glycoproteins">glycoproteins</a>
<ul>
<li><a href="/wiki/Template:Glycoprotein_metabolism_enzymes" title="Template:Glycoprotein metabolism enzymes">enzymes</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Glycosaminoglycans" title="Template:Glycosaminoglycans">glycosaminoglycans</a>
<ul>
<li><a href="/wiki/Template:Proteoglycan_metabolism_enzymes" title="Template:Proteoglycan metabolism enzymes">proteoglycan enzymes</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Phospholipids" title="Template:Phospholipids">phospholipid</a>
<ul>
<li><a href="/wiki/Template:Phospholipid_metabolism" title="Template:Phospholipid metabolism">metabolism</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Cholesterol_and_steroid_metabolism_enzymes" title="Template:Cholesterol and steroid metabolism enzymes">cholesterol and steroid</a>
<ul>
<li><a href="/wiki/Template:Cholesterol_and_steroid_intermediates" title="Template:Cholesterol and steroid intermediates">intermediates</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Sphingolipids" title="Template:Sphingolipids">sphingolipids</a>
<ul>
<li><a href="/wiki/Template:Glycolipid/sphingolipid_metabolism_enzymes" title="Template:Glycolipid/sphingolipid metabolism enzymes" class="mw-redirect">enzymes</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Eicosanoids" title="Template:Eicosanoids">eicosanoids</a>
<ul>
<li><a href="/wiki/Template:Eicosanoid_metabolism_enzymes" title="Template:Eicosanoid metabolism enzymes">enzymes</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Amino_acid_metabolism_enzymes" title="Template:Amino acid metabolism enzymes">amino acid</a>
<ul>
<li><a href="/wiki/Template:Amino_acid_metabolism_intermediates" title="Template:Amino acid metabolism intermediates">intermediates</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Urea_cycle" title="Template:Urea cycle">urea cycle</a>
<ul>
<li><a href="/wiki/Template:Urea_cycle_enzymes" title="Template:Urea cycle enzymes">enzymes</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Nucleotide_metabolism_enzymes" title="Template:Nucleotide metabolism enzymes">nucleotide</a>
<ul>
<li><a href="/wiki/Template:Nucleotide_metabolism_intermediates" title="Template:Nucleotide metabolism intermediates">intermediates</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Disorders</th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Disorders_of_TCA_and_ETC" title="Template:Disorders of TCA and ETC">Citric acid cycle and electron transport chain</a></li>
<li><a href="/wiki/Template:Glycoprotein_disorders" title="Template:Glycoprotein disorders">Glycoprotein</a></li>
<li><a href="/wiki/Template:Proteoglycan_disorders" title="Template:Proteoglycan disorders">Proteoglycan</a></li>
<li><a href="/wiki/Template:Fatty-acid_metabolism_disorders" title="Template:Fatty-acid metabolism disorders">Fatty-acid</a></li>
<li><a href="/wiki/Template:Phospholipid_metabolism_disorders" title="Template:Phospholipid metabolism disorders">Phospholipid</a></li>
<li><a href="/wiki/Template:Defects_of_cholesterol_and_steroid_metabolism" title="Template:Defects of cholesterol and steroid metabolism">Cholesterol and steroid</a></li>
<li><a href="/wiki/Template:Eicosanoid_metabolism_disorders" title="Template:Eicosanoid metabolism disorders">Eicosanoid</a></li>
<li><a href="/wiki/Template:Amino_acid_metabolic_pathology" title="Template:Amino acid metabolic pathology">Amino acid</a></li>
<li><a href="/wiki/Template:Inborn_errors_of_purine-pyrimidine_metabolism" title="Template:Inborn errors of purine-pyrimidine metabolism">Purine-pyrimidine</a></li>
<li><a href="/wiki/Template:Heme_metabolism_disorders" title="Template:Heme metabolism disorders">Heme metabolism</a></li>
<li><a href="/wiki/Template:Eponymous_medical_signs_for_endocrinology,_nutrition,_and_metabolism" title="Template:Eponymous medical signs for endocrinology, nutrition, and metabolism">Symptoms and signs</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Treatment</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li>Drugs
<ul>
<li><a href="/wiki/Template:Other_alimentary_tract_and_metabolism_products" title="Template:Other alimentary tract and metabolism products">other</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
</table>


<!-- 
NewPP limit report
Parsed by mw1165
CPU time usage: 0.390 seconds
Real time usage: 0.466 seconds
Preprocessor visited node count: 2200/1000000
Preprocessor generated node count: 0/1500000
Post‐expand include size: 119115/2097152 bytes
Template argument size: 801/2097152 bytes
Highest expansion depth: 9/40
Expensive parser function count: 0/500
Lua time usage: 0.112/10.000 seconds
Lua memory usage: 2.98 MB/50 MB
-->

<!-- 
Transclusion expansion time report (%,ms,calls,template)
100.00%  343.737      1 - -total
 37.40%  128.542      1 - Template:Reflist
 26.75%   91.934      1 - Template:Infobox_disease
 24.91%   85.638      7 - Template:Navbox
 23.27%   80.003      1 - Template:Infobox
 20.90%   71.845     14 - Template:Cite_journal
 12.71%   43.679      1 - Template:Lipidemias
  8.39%   28.835      2 - Template:Metabolic_navs
  6.87%   23.605      1 - Template:Fatty-acid_metabolism_disorders
  4.78%   16.417      2 - Template:Namespace_detect
-->

<!-- Saved in parser cache with key enwiki:pcache:idhash:2525632-0!*!0!!en!4!* and timestamp 20150704215435 and revision id 659864798
 -->
<noscript><img src="//en.wikipedia.org/wiki/Special:CentralAutoLogin/start?type=1x1" alt="" title="" width="1" height="1" style="border: none; position: absolute;" /></noscript></div>					<div class="printfooter">
						Retrieved from "<a dir="ltr" href="https://en.wikipedia.org/w/index.php?title=Carnitine_palmitoyltransferase_II_deficiency&amp;oldid=659864798">https://en.wikipedia.org/w/index.php?title=Carnitine_palmitoyltransferase_II_deficiency&amp;oldid=659864798</a>"					</div>
				<div id='catlinks' class='catlinks'><div id="mw-normal-catlinks" class="mw-normal-catlinks"><a href="/wiki/Help:Category" title="Help:Category">Categories</a>: <ul><li><a href="/wiki/Category:Autosomal_recessive_disorders" title="Category:Autosomal recessive disorders">Autosomal recessive disorders</a></li><li><a href="/wiki/Category:Hepatology" title="Category:Hepatology">Hepatology</a></li><li><a href="/wiki/Category:Fatty-acid_metabolism_disorders" title="Category:Fatty-acid metabolism disorders">Fatty-acid metabolism disorders</a></li></ul></div><div id="mw-hidden-catlinks" class="mw-hidden-catlinks mw-hidden-cats-hidden">Hidden categories: <ul><li><a href="/wiki/Category:Articles_with_contributors_link" title="Category:Articles with contributors link">Articles with contributors link</a></li><li><a href="/wiki/Category:Articles_that_use_a_Medicine_navs_subtemplate" title="Category:Articles that use a Medicine navs subtemplate">Articles that use a Medicine navs subtemplate</a></li></ul></div></div>				<div class="visualClear"></div>
							</div>
		</div>
		<div id="mw-navigation">
			<h2>Navigation menu</h2>

			<div id="mw-head">
									<div id="p-personal" role="navigation" class="" aria-labelledby="p-personal-label">
						<h3 id="p-personal-label">Personal tools</h3>
						<ul>
							<li id="pt-createaccount"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Carnitine+palmitoyltransferase+II+deficiency&amp;type=signup" title="You are encouraged to create an account and log in; however, it is not mandatory">Create account</a></li><li id="pt-login"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Carnitine+palmitoyltransferase+II+deficiency" title="You're encouraged to log in; however, it's not mandatory. [o]" accesskey="o">Log in</a></li>						</ul>
					</div>
									<div id="left-navigation">
										<div id="p-namespaces" role="navigation" class="vectorTabs" aria-labelledby="p-namespaces-label">
						<h3 id="p-namespaces-label">Namespaces</h3>
						<ul>
															<li  id="ca-nstab-main" class="selected"><span><a href="/wiki/Carnitine_palmitoyltransferase_II_deficiency"  title="View the content page [c]" accesskey="c">Article</a></span></li>
															<li  id="ca-talk"><span><a href="/wiki/Talk:Carnitine_palmitoyltransferase_II_deficiency"  title="Discussion about the content page [t]" accesskey="t" rel="discussion">Talk</a></span></li>
													</ul>
					</div>
										<div id="p-variants" role="navigation" class="vectorMenu emptyPortlet" aria-labelledby="p-variants-label">
												<h3 id="p-variants-label">
							<span>Variants</span><a href="#"></a>
						</h3>

						<div class="menu">
							<ul>
															</ul>
						</div>
					</div>
									</div>
				<div id="right-navigation">
										<div id="p-views" role="navigation" class="vectorTabs" aria-labelledby="p-views-label">
						<h3 id="p-views-label">Views</h3>
						<ul>
															<li id="ca-view" class="selected"><span><a href="/wiki/Carnitine_palmitoyltransferase_II_deficiency" >Read</a></span></li>
															<li id="ca-edit"><span><a href="/w/index.php?title=Carnitine_palmitoyltransferase_II_deficiency&amp;action=edit"  title="Edit this page [e]" accesskey="e">Edit</a></span></li>
															<li id="ca-history" class="collapsible"><span><a href="/w/index.php?title=Carnitine_palmitoyltransferase_II_deficiency&amp;action=history"  title="Past versions of this page [h]" accesskey="h">View history</a></span></li>
													</ul>
					</div>
										<div id="p-cactions" role="navigation" class="vectorMenu emptyPortlet" aria-labelledby="p-cactions-label">
						<h3 id="p-cactions-label"><span>More</span><a href="#"></a></h3>

						<div class="menu">
							<ul>
															</ul>
						</div>
					</div>
										<div id="p-search" role="search">
						<h3>
							<label for="searchInput">Search</label>
						</h3>

						<form action="/w/index.php" id="searchform">
							<div id="simpleSearch">
							<input type="search" name="search" placeholder="Search" title="Search Wikipedia [f]" accesskey="f" id="searchInput" /><input type="hidden" value="Special:Search" name="title" /><input type="submit" name="fulltext" value="Search" title="Search Wikipedia for this text" id="mw-searchButton" class="searchButton mw-fallbackSearchButton" /><input type="submit" name="go" value="Go" title="Go to a page with this exact name if one exists" id="searchButton" class="searchButton" />							</div>
						</form>
					</div>
									</div>
			</div>
			<div id="mw-panel">
				<div id="p-logo" role="banner"><a class="mw-wiki-logo" href="/wiki/Main_Page"  title="Visit the main page"></a></div>
						<div class="portal" role="navigation" id='p-navigation' aria-labelledby='p-navigation-label'>
			<h3 id='p-navigation-label'>Navigation</h3>

			<div class="body">
									<ul>
						<li id="n-mainpage-description"><a href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z">Main page</a></li><li id="n-contents"><a href="/wiki/Portal:Contents" title="Guides to browsing Wikipedia">Contents</a></li><li id="n-featuredcontent"><a href="/wiki/Portal:Featured_content" title="Featured content – the best of Wikipedia">Featured content</a></li><li id="n-currentevents"><a href="/wiki/Portal:Current_events" title="Find background information on current events">Current events</a></li><li id="n-randompage"><a href="/wiki/Special:Random" title="Load a random article [x]" accesskey="x">Random article</a></li><li id="n-sitesupport"><a href="https://donate.wikimedia.org/wiki/Special:FundraiserRedirector?utm_source=donate&amp;utm_medium=sidebar&amp;utm_campaign=C13_en.wikipedia.org&amp;uselang=en" title="Support us">Donate to Wikipedia</a></li><li id="n-shoplink"><a href="//shop.wikimedia.org" title="Visit the Wikimedia Shop">Wikipedia store</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-interaction' aria-labelledby='p-interaction-label'>
			<h3 id='p-interaction-label'>Interaction</h3>

			<div class="body">
									<ul>
						<li id="n-help"><a href="/wiki/Help:Contents" title="Guidance on how to use and edit Wikipedia">Help</a></li><li id="n-aboutsite"><a href="/wiki/Wikipedia:About" title="Find out about Wikipedia">About Wikipedia</a></li><li id="n-portal"><a href="/wiki/Wikipedia:Community_portal" title="About the project, what you can do, where to find things">Community portal</a></li><li id="n-recentchanges"><a href="/wiki/Special:RecentChanges" title="A list of recent changes in the wiki [r]" accesskey="r">Recent changes</a></li><li id="n-contactpage"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact page</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-tb' aria-labelledby='p-tb-label'>
			<h3 id='p-tb-label'>Tools</h3>

			<div class="body">
									<ul>
						<li id="t-whatlinkshere"><a href="/wiki/Special:WhatLinksHere/Carnitine_palmitoyltransferase_II_deficiency" title="List of all English Wikipedia pages containing links to this page [j]" accesskey="j">What links here</a></li><li id="t-recentchangeslinked"><a href="/wiki/Special:RecentChangesLinked/Carnitine_palmitoyltransferase_II_deficiency" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</a></li><li id="t-upload"><a href="/wiki/Wikipedia:File_Upload_Wizard" title="Upload files [u]" accesskey="u">Upload file</a></li><li id="t-specialpages"><a href="/wiki/Special:SpecialPages" title="A list of all special pages [q]" accesskey="q">Special pages</a></li><li id="t-permalink"><a href="/w/index.php?title=Carnitine_palmitoyltransferase_II_deficiency&amp;oldid=659864798" title="Permanent link to this revision of the page">Permanent link</a></li><li id="t-info"><a href="/w/index.php?title=Carnitine_palmitoyltransferase_II_deficiency&amp;action=info" title="More information about this page">Page information</a></li><li id="t-wikibase"><a href="//www.wikidata.org/wiki/Q2033861" title="Link to connected data repository item [g]" accesskey="g">Wikidata item</a></li><li id="t-cite"><a href="/w/index.php?title=Special:CiteThisPage&amp;page=Carnitine_palmitoyltransferase_II_deficiency&amp;id=659864798" title="Information on how to cite this page">Cite this page</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-coll-print_export' aria-labelledby='p-coll-print_export-label'>
			<h3 id='p-coll-print_export-label'>Print/export</h3>

			<div class="body">
									<ul>
						<li id="coll-create_a_book"><a href="/w/index.php?title=Special:Book&amp;bookcmd=book_creator&amp;referer=Carnitine+palmitoyltransferase+II+deficiency">Create a book</a></li><li id="coll-download-as-rdf2latex"><a href="/w/index.php?title=Special:Book&amp;bookcmd=render_article&amp;arttitle=Carnitine+palmitoyltransferase+II+deficiency&amp;oldid=659864798&amp;writer=rdf2latex">Download as PDF</a></li><li id="t-print"><a href="/w/index.php?title=Carnitine_palmitoyltransferase_II_deficiency&amp;printable=yes" title="Printable version of this page [p]" accesskey="p">Printable version</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-lang' aria-labelledby='p-lang-label'>
			<h3 id='p-lang-label'>Languages</h3>

			<div class="body">
									<ul>
						<li class="interlanguage-link interwiki-es"><a href="//es.wikipedia.org/wiki/Deficiencia_de_carnitina_palmitoiltransferasa_tipo_II" title="Deficiencia de carnitina palmitoiltransferasa tipo II – Spanish" lang="es" hreflang="es">Español</a></li><li class="interlanguage-link interwiki-fr"><a href="//fr.wikipedia.org/wiki/D%C3%A9ficit_en_carnitine_palmitoyltransf%C3%A9rase_II" title="Déficit en carnitine palmitoyltransférase II – French" lang="fr" hreflang="fr">Français</a></li><li class="uls-p-lang-dummy"><a href="#"></a></li>					</ul>
				<div class='after-portlet after-portlet-lang'><span class="wb-langlinks-edit wb-langlinks-link"><a href="//www.wikidata.org/wiki/Q2033861#sitelinks-wikipedia" title="Edit interlanguage links" class="wbc-editpage">Edit links</a></span></div>			</div>
		</div>
				</div>
		</div>
		<div id="footer" role="contentinfo">
							<ul id="footer-info">
											<li id="footer-info-lastmod"> This page was last modified on 29 April 2015, at 12:40.</li>
											<li id="footer-info-copyright">Text is available under the <a rel="license" href="//en.wikipedia.org/wiki/Wikipedia:Text_of_Creative_Commons_Attribution-ShareAlike_3.0_Unported_License">Creative Commons Attribution-ShareAlike License</a><a rel="license" href="//creativecommons.org/licenses/by-sa/3.0/" style="display:none;"></a>;
additional terms may apply.  By using this site, you agree to the <a href="//wikimediafoundation.org/wiki/Terms_of_Use">Terms of Use</a> and <a href="//wikimediafoundation.org/wiki/Privacy_policy">Privacy Policy</a>. Wikipedia® is a registered trademark of the <a href="//www.wikimediafoundation.org/">Wikimedia Foundation, Inc.</a>, a non-profit organization.</li>
									</ul>
							<ul id="footer-places">
											<li id="footer-places-privacy"><a href="//wikimediafoundation.org/wiki/Privacy_policy" title="wikimedia:Privacy policy">Privacy policy</a></li>
											<li id="footer-places-about"><a href="/wiki/Wikipedia:About" title="Wikipedia:About">About Wikipedia</a></li>
											<li id="footer-places-disclaimer"><a href="/wiki/Wikipedia:General_disclaimer" title="Wikipedia:General disclaimer">Disclaimers</a></li>
											<li id="footer-places-contact"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact Wikipedia</a></li>
											<li id="footer-places-developers"><a href="https://www.mediawiki.org/wiki/Special:MyLanguage/How_to_contribute">Developers</a></li>
											<li id="footer-places-mobileview"><a href="//en.m.wikipedia.org/w/index.php?title=Carnitine_palmitoyltransferase_II_deficiency&amp;mobileaction=toggle_view_mobile" class="noprint stopMobileRedirectToggle">Mobile view</a></li>
									</ul>
										<ul id="footer-icons" class="noprint">
											<li id="footer-copyrightico">
							<a href="//wikimediafoundation.org/"><img src="/static/images/wikimedia-button.png" srcset="/static/images/wikimedia-button-1.5x.png 1.5x, /static/images/wikimedia-button-2x.png 2x" width="88" height="31" alt="Wikimedia Foundation"/></a>						</li>
											<li id="footer-poweredbyico">
							<a href="//www.mediawiki.org/"><img src="//en.wikipedia.org/static/1.26wmf13/resources/assets/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" srcset="//en.wikipedia.org/static/1.26wmf13/resources/assets/poweredby_mediawiki_132x47.png 1.5x, //en.wikipedia.org/static/1.26wmf13/resources/assets/poweredby_mediawiki_176x62.png 2x" width="88" height="31" /></a>						</li>
									</ul>
						<div style="clear:both"></div>
		</div>
		<script>if(window.jQuery)jQuery.ready();</script><script>if(window.mw){
mw.loader.state({"ext.globalCssJs.site":"ready","ext.globalCssJs.user":"ready","site":"loading","user":"ready","user.groups":"ready"});
}</script>
<link rel="stylesheet" href="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=ext.cite.styles%7Cext.gadget.DRN-wizard%2CReferenceTooltips%2CWatchlistGreenIndicators%2Ccharinsert%2Cfeatured-articles-links%2CrefToolbar%2Cswitcher%2Cteahouse%7Cext.wikimediaBadges&amp;only=styles&amp;skin=vector&amp;*" />
<script>if(window.mw){
mw.loader.load(["ext.cite.a11y","mediawiki.toc","mediawiki.action.view.postEdit","mediawiki.user","mediawiki.hidpi","mediawiki.page.ready","mediawiki.searchSuggest","ext.cirrusSearch.loggingSchema","mmv.bootstrap.autostart","ext.imageMetrics.loader","ext.eventLogging.subscriber","ext.wikimediaEvents","ext.wikimediaEvents.statsd","ext.navigationTiming","ext.gadget.teahouse","ext.gadget.ReferenceTooltips","ext.gadget.WatchlistGreenIndicators","ext.gadget.DRN-wizard","ext.gadget.charinsert","ext.gadget.refToolbar","ext.gadget.switcher","ext.gadget.featured-articles-links","ext.visualEditor.targetLoader","schema.UniversalLanguageSelector","ext.uls.eventlogger","ext.uls.interlanguage"],null,true);
}</script>
<script>if(window.mw){
document.write("\u003Cscript src=\"//en.wikipedia.org/w/load.php?debug=false\u0026amp;lang=en\u0026amp;modules=site\u0026amp;only=scripts\u0026amp;skin=vector\u0026amp;*\"\u003E\u003C/script\u003E");
}</script>
<script>if(window.mw){
mw.config.set({"wgBackendResponseTime":70,"wgHostname":"mw1238"});
}</script>
	</body>
</html>
